Covariates were: centrally reviewed Gleason grade, baseline PSA value, clinical stage, extent of disease (proportion of positive cores), age at diagnosis, and initial hormone management.
In the sensitivity analysis excluding trials with a significant proportion of non-metastastic, locally advanced disease (proportion with metastases < 80%), 15 trials were included.
Covariates evaluated were centrally reviewed Gleason score, baseline PSA value, clinical stage, extent of disease (proportion of positive chips), age at diagnosis and Ki-67 score (% cells positive).
Covariates evaluated were: centrally reviewed Gleason primary grade and score, baseline PSA value, clinical stage, extent of disease (proportion of positive cores), age at diagnosis, Ki-67 immunohistochemistry, and initial treatment (no initial treatment or early hormone management).
In any scenario, the assumptions concerning ART distribution, patterns of progression of disease, proportion of patients who experience adverse drug reactions, or numbers lost to follow up will all change the FTE requirements generated.
The following variables were recorded: Gleason score, all available PSA values, clinical stage, extent of disease (proportion of TURP chips with disease or linear proportion of needle biopsy containing disease), age at diagnosis, method of diagnosis (TURP or needle biopsy), and initial treatment (no initial treatment or early hormone management).
Comparing disease proportions, the coincident cohort tended to have higher frequencies for each adverse outcome (Figure 2).
Disease proportions attributable to various causal agents are figures popular with scientists, decision makers, and lay people.
Population disease proportions attributable to various causal agents are popular as they present a simplified view of the contribution of each agent to the disease load.
To investigate the host resistance to bakanae disease, the proportion of healthy plants in Wonseadaesoo (resistant) and Junam (susceptible) were measured after inoculation with virulent F. fujikuroi isolate CF283 (Kim et al. 2014).
Our response variable was disease prevalence (proportion of colonies surveyed affected by GAs) within the survey areas.
